COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection

The global coronavirus disease 2019 (COVID-19) pandemic caused by the SARS-CoV-2 coronavirus started in March 2020. The conclusions from numerous studies indicate that people with comorbidities, such as arterial hypertension, diabetes, obesity, underlying cardiovascular disease, are particularly vul...

Descripción completa

Detalles Bibliográficos
Autores principales: Surma, Stanisław, Banach, Maciej, Lewek, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542506/
https://www.ncbi.nlm.nih.gov/pubmed/34689776
http://dx.doi.org/10.1186/s12944-021-01563-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542506/
https://www.ncbi.nlm.nih.gov/pubmed/34689776
http://dx.doi.org/10.1186/s12944-021-01563-0

Ejemplares similares